Pharmacy Department, The Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, China.
Thromb Res. 2010 Apr;125(4):e159-66. doi: 10.1016/j.thromres.2009.10.017. Epub 2009 Nov 25.
Warfarin is the most widely used oral anticoagulant. It has been suggested that anticoagulation effect of warfarin is significantly associated with the polymorphism of certain genes, including Cytochrome P450 complex subunit 2C9 (CYP2C9), Vitamin K Epoxide Reductase Complex Subunit 1 (VKORC1), Gamma-Glutamyl Carboxylase (GGCX) and Apolipoprotein E (APOE) etc. The purpose of the present study was to conduct a systemic review and meta-analysis to investigate the relationship between mean daily warfarin dose (MDWD) and VKORC1 single nucleotide polymorphisms (SNPs).
Inclusion and exclusion criteria were made, and the studies between 2004 and present were searched. References were examined, and experts were consulted for additional information. Data were extracted. Revman 4.2.10 software was applied to analyze the relationship between MDWD and VKORC1 SNPs.
Total 19 studies were included in the meta-analysis. The frequencies of 1173TT and -1639 AA in Asian patients were higher than those in Caucasian and African populations. Patients with VKORC1 1173 CT and 1173 CC required 44% [95% Confidence Interval (CI); 32%, 56%] and 97% [73%, 122%] higher MDWD than 1173 TT carriers, -1639GA and -1639GG carriers required 52% [41%, 64%] and 102% [85%, 118%] higher MDWD than -1639AA carriers, 3730GA and 3730AA carriers required 27% [3%, 58%] and 52% [3%, 109%] higher MDWD than 3730GG carriers. In addition, 1173C, -1639 G and 3730 A carriers required 63% [44%, 82%], 61% [49%, 73%] and 32% [4%, 59%] higher MDWD than 1173TT, -1639 AA and 3730GG, respectively. Sensitive analyses demonstrated that the impacts of gene polymorphism on warfarin dosage requirement were significantly different between Caucasian and Asian population, and the results of meta-analyses were stable and reliable.
This is the first meta-analysis about the impact of VKORC1 gene polymorphism on warfarin dose requirement. Our studies showed that gene polymorphisms of VKORC1 significantly associated with the variation of interindividual warfarin dose requirement variation, and the effects are different in ethnicities.
华法林是最广泛使用的口服抗凝剂。已经有研究表明,华法林的抗凝效果与某些基因的多态性显著相关,包括细胞色素 P450 酶复合 2C9(CYP2C9)、维生素 K 环氧化物还原酶复合体亚单位 1(VKORC1)、γ-谷氨酰羧化酶(GGCX)和载脂蛋白 E(APOE)等。本研究旨在进行系统评价和荟萃分析,以研究 VKORC1 单核苷酸多态性(SNP)与平均每日华法林剂量(MDWD)之间的关系。
制定了纳入和排除标准,并对 2004 年至今的研究进行了检索。查阅了参考文献,并咨询了专家以获取其他信息。提取数据。采用 Revman 4.2.10 软件分析 MDWD 与 VKORC1 SNPs 之间的关系。
共有 19 项研究纳入荟萃分析。亚洲患者中 1173TT 和-1639AA 的频率高于白种人和非裔人群。VKORC1 1173 CT 和 1173 CC 患者需要比 1173 TT 携带者高 44%[95%置信区间(CI);32%,56%]和 97%[73%,122%]的 MDWD,-1639GA 和-1639GG 携带者需要比-1639AA 携带者高 52%[41%,64%]和 102%[85%,118%]的 MDWD,3730GA 和 3730AA 携带者需要比 3730GG 携带者高 27%[3%,58%]和 52%[3%,109%]的 MDWD。此外,1173C、-1639G 和 3730A 携带者需要比 1173TT、-1639AA 和 3730GG 携带者高 63%[44%,82%]、61%[49%,73%]和 32%[4%,59%]的 MDWD。敏感性分析表明,基因多态性对华法林剂量需求的影响在白种人和亚洲人群之间存在显著差异,荟萃分析结果稳定可靠。
这是第一项关于 VKORC1 基因多态性对华法林剂量需求影响的荟萃分析。我们的研究表明,VKORC1 基因多态性与个体间华法林剂量需求的变化显著相关,其影响在种族之间存在差异。